Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiNardo

Showing results (1081-1090 of 1,482) with videos related to

Pageof 149
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2018
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid LeukemiaKiyomi Morita, Hagop M Kantarjian, Feng Wang, et al.
Blood|September 7, 2018
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosisLucia Masarova, Srdan Verstovsek, Juliana E Hidalgo-Lopez, et al.
Journal of Hematology & Oncology|October 9, 2020
Outcomes with sequential FLT3-inhibitor-based therapies in patients with AMLMusa Yilmaz, Mansour Alfayez, Courtney D DiNardo, et al.
American Journal of Hematology|February 8, 2025
Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary TherapiesJayastu Senapati, Sanam Loghavi, Jennifer Marvin-Peek, et al.
Blood Advances|February 24, 2026
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapyAndrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, et al.
Blood|May 5, 2022
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasmsAdam S Sperling, Veronica A Guerra, James A Kennedy, et al.
Cancer Discovery|November 10, 2018
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II StudyNaval Daver, Guillermo Garcia-Manero, Sreyashi Basu, et al.
The Journal of Pediatrics|September 24, 2020
Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology DisordersRyan W Himes, Eric H Chiou, Karen Queliza, et al.
Cancer|August 7, 2025
Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemiaJayastu Senapati, Hagop M Kantarjian, Tapan M Kadia, et al.
JCO Precision Oncology|December 10, 2025
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute LeukemiaHannah Goulart, Farhad Ravandi, Nicholas J Short, et al.
Pageof 149

Showing results (1081-1090 of 1,482) with videos related to

Sort By:
Pageof 149
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2018
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid LeukemiaKiyomi Morita, Hagop M Kantarjian, Feng Wang, et al.
Blood|September 7, 2018
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosisLucia Masarova, Srdan Verstovsek, Juliana E Hidalgo-Lopez, et al.
Journal of Hematology & Oncology|October 9, 2020
Outcomes with sequential FLT3-inhibitor-based therapies in patients with AMLMusa Yilmaz, Mansour Alfayez, Courtney D DiNardo, et al.
American Journal of Hematology|February 8, 2025
Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary TherapiesJayastu Senapati, Sanam Loghavi, Jennifer Marvin-Peek, et al.
Blood Advances|February 24, 2026
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapyAndrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, et al.
Blood|May 5, 2022
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasmsAdam S Sperling, Veronica A Guerra, James A Kennedy, et al.
Cancer Discovery|November 10, 2018
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II StudyNaval Daver, Guillermo Garcia-Manero, Sreyashi Basu, et al.
The Journal of Pediatrics|September 24, 2020
Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology DisordersRyan W Himes, Eric H Chiou, Karen Queliza, et al.
Cancer|August 7, 2025
Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemiaJayastu Senapati, Hagop M Kantarjian, Tapan M Kadia, et al.
JCO Precision Oncology|December 10, 2025
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute LeukemiaHannah Goulart, Farhad Ravandi, Nicholas J Short, et al.
Pageof 149